Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.
Lloyd MR, Chica-Parrado R, Weipert CM, Knepper TC, Podany EL, Napolitano F, Ye D, Lin CC, Uemoto Y, Liao J, Wegrzyn C, Walko CM, Ryan LY, Keenan JC, Medford AJ, Liu SA, Wulf GM, Clifton KK, Ma CX, Han HS, Zhang N, Ellisen LW, Bardia A, Arteaga CL, Hanker AB, Wander SA. Lloyd MR, et al. Among authors: weipert cm. EBioMedicine. 2025 Jun 26;118:105828. doi: 10.1016/j.ebiom.2025.105828. Online ahead of print. EBioMedicine. 2025. PMID: 40578027 Free article.
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.
Rousseau B, Patel M, Artz O, Vlachos G, Patel S, Hayatt O, Argilés G, Foote MB, Luo L, Shah R, Mehta S, Rangavajhula K, Stewart CM, Gerber D, Bhattacharya R, Stephens D, Mieles D, Randrian V, Abdelfattah S, Zhang L, Membreno-Berganza N, Lamendola-Essel MF, Piastra-Facon F, Vidal J, Johannet P, Lu S, White JR, Maron SB, Barlas A, Weipert CM, Rosiek E, Zhang T, He B, Monette S, Qu R, Fidele D, Bowker S, Kahn A, Vitiello PP, Germano G, Bardelli A, Mandal R, Ma X, Chan TA, Lu S, Cercek A, Abdel-Wahab O, de Stanchina E, Segal NH, Diaz LA Jr. Rousseau B, et al. Among authors: weipert cm. Cancer Cell. 2025 Jun 12:S1535-6108(25)00219-3. doi: 10.1016/j.ccell.2025.05.010. Online ahead of print. Cancer Cell. 2025. PMID: 40513573
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
Konstantinopoulos PA, Cai M, Lee EK, Krasner C, Campos SM, Liu JF, Horowitz NS, Shea M, Parsons HA, Wright AA, Bouberhan S, Penson RT, Yeku O, Hayes M, Sawyer H, Polak M, Castro CM, Cheng SC, Weipert CM, Matulonis UA. Konstantinopoulos PA, et al. Among authors: weipert cm. JCO Precis Oncol. 2025 Apr;9:e2400882. doi: 10.1200/PO-24-00882. Epub 2025 Apr 10. JCO Precis Oncol. 2025. PMID: 40209137 Clinical Trial.
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.
Abelman RO, Wu B, Barnes H, Medford A, Norden B, Putur A, Bitman E, Thant W, Liu T, Weipert C, Fell G, Spring LM, Wander SA, Moy B, Vidula N, Isakoff SJ, Varkaris A, Juric D, Corcoran RB, Ellisen LW, Bardia A. Abelman RO, et al. Among authors: weipert c. Clin Cancer Res. 2025 May 15;31(10):1966-1974. doi: 10.1158/1078-0432.CCR-24-2771. Clin Cancer Res. 2025. PMID: 39745368 Free PMC article.
CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breast Cancer.
Lloyd MR, Brett JO, Carmeli A, Weipert CM, Zhang N, Yu J, Bucheit L, Medford AJ, Wagle N, Bardia A, Wander SA. Lloyd MR, et al. Among authors: weipert cm. NEJM Evid. 2024 May;3(5):EVIDoa2300231. doi: 10.1056/EVIDoa2300231. Epub 2024 Apr 23. NEJM Evid. 2024. PMID: 38815172
26 results